医用重组胶原蛋白液体敷料
Search documents
珀莱雅:上新红宝石微珠精华,建议关注后续新品表现-20260211
Guolian Minsheng Securities· 2026-02-10 13:25
Investment Rating - The report maintains a "Buy" rating for Proya (603605.SH) with a current price of 75.51 CNY [3]. Core Insights - Proya launched a new product, the Ruby Microbead Essence, priced at 299 CNY for 30ml, targeting a broad customer base with its unique formulation [9]. - The company is actively expanding its product matrix across multiple brands, including skincare, makeup, and hair care, which is expected to enhance growth potential [9]. - Proya's revenue projections for 2025-2027 are 109.94 billion CNY, 126.65 billion CNY, and 139.95 billion CNY, with respective growth rates of 2.0%, 15.2%, and 10.5% [9]. Financial Forecasts - Revenue (in million CNY) is projected to be 10,778 for 2024, 10,994 for 2025, 12,665 for 2026, and 13,995 for 2027, with growth rates of 21.0%, 2.0%, 15.2%, and 10.5% respectively [2]. - Net profit attributable to shareholders (in million CNY) is expected to be 1,552 for 2024, 1,592 for 2025, 1,859 for 2026, and 2,063 for 2027, with growth rates of 30.0%, 2.5%, 16.8%, and 11.0% respectively [2]. - Earnings per share (CNY) are forecasted to be 3.92 for 2024, 4.02 for 2025, 4.69 for 2026, and 5.21 for 2027 [2]. Product Development and Strategy - Proya is focusing on new product launches to cater to diverse consumer needs, including the MED series for specific skin repair scenarios and a new men's skincare line [9]. - The company is also implementing a share buyback plan to demonstrate confidence in its future growth, with a total buyback amounting to 0.8-1.5 billion CNY [9].
珀莱雅(603605):上新红宝石微珠精华,建议关注后续新品表现
Guolian Minsheng Securities· 2026-02-10 12:01
Investment Rating - The report maintains a "Buy" rating for Proya, indicating a positive outlook for the company's stock performance relative to the benchmark index [3][12]. Core Insights - Proya launched a new product, the Ruby Microbead Essence, priced at 299 RMB for 30ml, targeting a broad customer base with its unique formulation [9]. - The company is actively expanding its product matrix across multiple brands, including skincare, makeup, and hair care, which is expected to enhance growth potential [9]. - Proya's revenue projections for 2025-2027 are 10.994 billion, 12.665 billion, and 13.995 billion RMB, with corresponding net profits of 1.592 billion, 1.859 billion, and 2.063 billion RMB, reflecting growth rates of 2.0%, 15.2%, and 10.5% respectively [2][10]. Financial Forecasts - Revenue and profit forecasts for Proya are as follows: - 2024A: Revenue of 10,778 million RMB, net profit of 1,552 million RMB - 2025E: Revenue of 10,994 million RMB, net profit of 1,592 million RMB - 2026E: Revenue of 12,665 million RMB, net profit of 1,859 million RMB - 2027E: Revenue of 13,995 million RMB, net profit of 2,063 million RMB [2][10]. - Earnings per share (EPS) are projected to be 3.92, 4.02, 4.69, and 5.21 RMB for the years 2024A to 2027E, respectively [2][10]. Market Position and Strategy - Proya's multi-brand strategy is designed to capture a wider consumer base and enhance market presence, with a focus on new product launches and brand collaborations [9]. - The company has initiated a share buyback program, reflecting confidence in its future growth and plans for employee stock ownership [9].